Targeting KRAS: Good, But Is It Good Enough?

Author: Margaret Tempero MD
View More View Less
  • 1.

    Skoulidis F, Li BT, Dy GK, et al. Sotorasib for lung cancers with KRAS p.G12C mutation. N Engl J Med 2021;384:23712381.

  • 2.

    Hong DS, Fakih MG, Strickler JH, et al. KRASG12C inhibition with sotorasib in advanced solid tumors. N Engl J Med 2020;383:12071217.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1290 1290 1290
PDF Downloads 705 705 705
EPUB Downloads 0 0 0